It might be a good time to ask, given our long and ardent relationship with this class of drugs despite their substantial liabilities, whether there is a better way to help those suffering with insomnia or anxiety. Or even to wonder how these conditions are so common as to be statistically normal—indeed they afflict at least one in three adults in the United States—yet still are considered abnormal behaviors.
